Supernus Pharmaceuticals
(NASDAQ:SUPN)
$35.58
At close: Dec 8(Delayed 15-Minutes)
Get Real Time Here
$35.58
PreMarket: 4:01PM EDT
Day Range- - -52 Wk Range24.950 - 37.890Open / Close- / -Float / Outstanding38.106M / 54.058M
Vol / Avg.0 / 389.308KMkt Cap1.923BP/E53.90950d Avg. Price34.240
Div / Yield (Forward)- / -%Payout Ratio-Total Float38.106MEPS0.710

Supernus Pharmaceuticals Stock (NASDAQ:SUPN), Quotes and News Summary

Supernus Pharmaceuticals Stock (NASDAQ: SUPN) stock price, news, charts, stock research, profile.

Loading...
Day Range- - -52 Wk Range24.950 - 37.890Open / Close- / -Float / Outstanding38.106M / 54.058M
Vol / Avg.0 / 389.308KMkt Cap1.923BP/E53.90950d Avg. Price34.240
Div / Yield (Forward)- / -%Payout Ratio-Total Float38.106MEPS0.710
Globe Newswire - Oct 10, 2022, 8:30AM
Seeking Alpha - Nov 29, 2022, 1:37PM
TalkMarkets - Aug 21, 2022, 5:46AM
Seeking Alpha - Jul 29, 2022, 4:15AM
Seeking Alpha - May 6, 2022, 5:35PM
Seeking Alpha - Apr 4, 2022, 6:05PM
Seeking Alpha - Mar 28, 2022, 7:17AM
Sector: Health Care.Industry: Pharmaceuticals
Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. The company products include Oxtellar XR, Trokendi XR, SPN-812, and others. The majority of the revenue is generated from the sale of Trokendi XR.

Earnings

see more
Q4 2022Est.ActualSurprise
EPS
(EXPECTED)2023-02-27
REV
Q3 2022Est.ActualSurprise
EPS0.3600.030 -0.3300
REV172.480M177.353M4.873M

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
Q

How do I buy Supernus Pharmaceuticals (SUPN) stock?

A

You can purchase shares of Supernus Pharmaceuticals (NASDAQ: SUPN) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Supernus Pharmaceuticals's (SUPN) competitors?

Q

What is the target price for Supernus Pharmaceuticals (SUPN) stock?

A

The latest price target for Supernus Pharmaceuticals (NASDAQ: SUPN) was reported by Piper Sandler on Wednesday, August 31, 2022. The analyst firm set a price target for 38.00 expecting SUPN to rise to within 12 months (a possible 6.80% upside). 1 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Supernus Pharmaceuticals (SUPN)?

A

The stock price for Supernus Pharmaceuticals (NASDAQ: SUPN) is $35.58 last updated December 8, 2022, 9:00 PM UTC.

Q

Does Supernus Pharmaceuticals (SUPN) pay a dividend?

A

There are no upcoming dividends for Supernus Pharmaceuticals.

Q

When is Supernus Pharmaceuticals (NASDAQ:SUPN) reporting earnings?

A

Supernus Pharmaceuticals’s Q4 earnings are confirmed for Monday, February 27, 2023.

Q

Is Supernus Pharmaceuticals (SUPN) going to split?

A

There is no upcoming split for Supernus Pharmaceuticals.

Q

What sector and industry does Supernus Pharmaceuticals (SUPN) operate in?

A

Supernus Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.